Last reviewed · How we verify
Placebo of Reconyl
Placebo of Reconyl is a Small molecule drug developed by Dexa Medica Group. It is currently in Phase 3 development for Treatment of symptoms in clinical trials.
This drug is a placebo, meaning it has no active therapeutic effect.
This drug is a placebo, meaning it has no active therapeutic effect. Used for Treatment of symptoms in clinical trials.
At a glance
| Generic name | Placebo of Reconyl |
|---|---|
| Sponsor | Dexa Medica Group |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease.
Approved indications
- Treatment of symptoms in clinical trials
Common side effects
Key clinical trials
- The Efficacy and Safety of Reconyl in Acute Cough Treatment (PHASE3)
- Safety and Efficacy Reconyl for Cough With/Without Sore Throat (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of Reconyl CI brief — competitive landscape report
- Placebo of Reconyl updates RSS · CI watch RSS
- Dexa Medica Group portfolio CI
Frequently asked questions about Placebo of Reconyl
What is Placebo of Reconyl?
How does Placebo of Reconyl work?
What is Placebo of Reconyl used for?
Who makes Placebo of Reconyl?
What development phase is Placebo of Reconyl in?
Related
- Manufacturer: Dexa Medica Group — full pipeline
- Indication: Drugs for Treatment of symptoms in clinical trials
- Compare: Placebo of Reconyl vs similar drugs
- Pricing: Placebo of Reconyl cost, discount & access